betulinic acid has been researched along with cyclin d1 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rieber, M; Strasberg Rieber, M | 1 |
| Kaczor, J; Kandefer-Szerszeń, M; Rzeski, W; Sifringer, M; Stepulak, A; Szymański, M; Wejksza, K; Zdzisińska, B | 1 |
| Chinthakindi, PK; Hamid, A; Hussain, A; Khan, I; Koul, S; Majeed, R; Sangwan, PL; Saxena, AK; Sharma, PR | 1 |
| Das, V; Ghosh, S; Giri, B; Kumar, A; Mandal, A; Mukhopadhyay, S; Sarkar, M | 1 |
4 other study(ies) available for betulinic acid and cyclin d1
| Article | Year |
|---|---|
Induction of p53 without increase in p21WAF1 in betulinic acid-mediated cell death is preferential for human metastatic melanoma.
Topics: Antineoplastic Agents, Phytogenic; Betulinic Acid; Cell Death; Cyclin D1; Cyclin D3; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA Damage; Drug Resistance, Neoplasm; Gelatinases; Gene Expression Regulation, Neoplastic; Humans; Melanoma; Neoplasm Metastasis; Pentacyclic Triterpenes; Triterpenes; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1998 |
Betulinic acid decreases expression of bcl-2 and cyclin D1, inhibits proliferation, migration and induces apoptosis in cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Betulinic Acid; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclin D1; Dose-Response Relationship, Drug; Humans; Neoplasms; Pentacyclic Triterpenes; Proto-Oncogene Proteins c-bcl-2; Triterpenes | 2006 |
PI3K target based novel cyano derivative of betulinic acid induces its signalling inhibition by down-regulation of pGSK3β and cyclin D1 and potentially checks cancer cell proliferation.
Topics: Betulinic Acid; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Down-Regulation; G1 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; HL-60 Cells; Humans; MCF-7 Cells; Neoplasms; Pentacyclic Triterpenes; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Signal Transduction; Triazoles; Triterpenes | 2016 |
Biological evaluation of a halogenated triterpenoid, 2α-bromo-dihydrobelulonic acid as inhibitor of human topoisomerase IIα and HeLa cell proliferation.
Topics: Antigens, Neoplasm; Apoptosis; Betulinic Acid; Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; DNA; DNA Topoisomerases, Type II; DNA-Binding Proteins; G1 Phase Cell Cycle Checkpoints; Halogenation; HeLa Cells; Humans; Intercalating Agents; Oleanolic Acid; Pentacyclic Triterpenes; Proliferating Cell Nuclear Antigen; Spectrometry, Fluorescence; Streptophyta; Topoisomerase II Inhibitors; Triterpenes | 2017 |